Radiopharm Theranostics Limited (AU:RAD) has released an update.
Radiopharm Theranostics Limited announced the successful passage of all resolutions at its Extraordinary General Meeting, signaling investor confidence and paving the way for future company initiatives. The resolutions, which included the approval of share issuances and ratifications, received overwhelming support with approval rates exceeding 88 percent across the board. This outcome demonstrates strong shareholder backing for Radiopharm’s strategic decisions.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.
